Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial).
Morozova M, Burminskiy D, Rupchev G, Lepilkina T, Potanin S, Beniashvili A, Lavrovsky Y, Vostokova N, Ivaschenko A. Morozova M, et al. J Clin Psychopharmacol. 2017 Apr;37(2):169-175. doi: 10.1097/JCP.0000000000000673. J Clin Psychopharmacol. 2017. PMID: 28141622 Clinical Trial.
[Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy].
Brusov OS, Faktor MI, Zlobina GP, Dupin AM, Katasonov AB, Kartseva NK, Beniashvili AG, Zharkova NB, Rubashkina VV, Morozova MA. Brusov OS, et al. Among authors: morozova ma. Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(3):27-34. Zh Nevrol Psikhiatr Im S S Korsakova. 2005. PMID: 15825226 Russian.
Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study.
Morozova MA, Lepilkina TA, Rupchev GE, Beniashvily AG, Burminskiy DS, Potanin SS, Bondarenko EV, Kazey VI, Lavrovsky Y, Ivachtchenko AV. Morozova MA, et al. CNS Spectr. 2014 Aug;19(4):316-23. doi: 10.1017/S1092852913000394. Epub 2013 Jun 17. CNS Spectr. 2014. PMID: 23768250 Clinical Trial.
[The use of acatinol in the treatment of stable patients with schizophrenia with predominance of behaviour disorganization and subcatatonic features].
Morozova MA, Rupchev GE, Kozhekin IG, Arsenieva TB, Cheremin RA, Yachmenev VN, Onegina EY, Shvedova AK, Beniashvili AG, Burminsky DS, Lepilkina TA, Potanin SS. Morozova MA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(1):35-41. Zh Nevrol Psikhiatr Im S S Korsakova. 2014. PMID: 24637815 Clinical Trial. Russian.
238 results